CHARLES SCHWAB INVESTMENT MANAGEMENT INC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 94 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$322,000
-76.2%
258,877
-41.0%
0.00%
-100.0%
Q1 2017$1,352,000
-20.5%
438,888
+5.4%
0.00%
-50.0%
Q4 2016$1,700,000
-32.5%
416,487
+5.1%
0.00%
-33.3%
Q3 2016$2,517,000
+6.5%
396,313
-9.6%
0.00%0.0%
Q2 2016$2,363,000
-34.4%
438,355
+1.9%
0.00%
-40.0%
Q1 2016$3,600,000
+11.5%
430,069
+5.2%
0.01%
+25.0%
Q4 2015$3,230,000
+14.3%
408,850
+23.2%
0.00%0.0%
Q3 2015$2,825,000
-29.3%
331,923
+2.8%
0.00%
-33.3%
Q2 2015$3,993,000
+11.3%
322,859
+6.9%
0.01%
+20.0%
Q1 2015$3,588,000
+10.1%
301,950
+4.7%
0.01%0.0%
Q4 2014$3,258,000
+36.2%
288,299
+5.8%
0.01%
+25.0%
Q3 2014$2,392,000
+22.7%
272,391
+1.9%
0.00%
+33.3%
Q2 2014$1,950,000
+57.1%
267,362
+8.7%
0.00%
+50.0%
Q1 2014$1,241,000
-3.3%
246,056
+2.5%
0.00%0.0%
Q4 2013$1,283,000
+49.5%
240,116
+9.2%
0.00%0.0%
Q3 2013$858,000
-24.6%
219,896
+33.8%
0.00%
-33.3%
Q2 2013$1,138,000164,3110.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2013
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders